Ms. Anoushka Saxena is an immunology researcher specializing in immune–metabolic dysregulation in viral hepatitis, acute liver failure, and pregnancy-associated infections. Her work integrates patient-based clinical research with advanced immune profiling, metabolomics, microbiome analysis, and multi-omics approaches to elucidate mechanisms underlying disease severity and adverse maternal–fetal outcomes. She has contributed important insights into hepatitis E, hepatitis A, and COVID-19 pathogenesis in pregnancy, supporting translational biomarker discovery and clinical risk stratification. Her research output has received scholarly recognition, with 11 citations, an h-index of 2, and consistent citation impact since 2020.